These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 118235)

  • 1. Characterization of infection and replication of Mason-Pfizer monkey virus in human cell cultures.
    Fine DL; Clarke GC; Arthur LO
    J Gen Virol; 1979 Aug; 44(2):457-69. PubMed ID: 118235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type D primate retroviruses: a review.
    Fine D; Schochetman G
    Cancer Res; 1978 Oct; 38(10):3123-39. PubMed ID: 80259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunodeficiency in rhesus monkeys associated with the original Mason-Pfizer monkey virus.
    Bryant ML; Gardner MB; Marx PA; Maul DH; Lerche NW; Osborn KG; Lowenstine LJ; Bodgen A; Arthur LO; Hunter E
    J Natl Cancer Inst; 1986 Oct; 77(4):957-65. PubMed ID: 3020302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative large-scale propagation of retroviruses from Old World (Mason-Pfizer monkey virus) and New World (squirrel monkey virus) primates.
    Benton CV; Hodge HM; Fine DL
    In Vitro; 1978 Feb; 14(2):192-9. PubMed ID: 78888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on human KC cell syncytia formation induced by Mason-Pfizer monkey virus.
    Ogura H; Oda T
    Acta Med Okayama; 1977 Aug; 31(4):243-7. PubMed ID: 145160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of simian type-C particles in Mason-Pfizer virus infected cultures.
    Ahmed M; Schidlovsky G; Larson DL; Manousos M; Mayyasi SA
    J Gen Virol; 1976 Jan; 30(1):11-20. PubMed ID: 54406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor promoter-stimulated synthesis of Mason-:Pfizer monkey virus.
    Wunderlich V; Baumbach L; Sydow G
    J Cancer Res Clin Oncol; 1982; 102(3):271-5. PubMed ID: 7061574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic analysis of the major structural protein of the Mason-Pfizer monkey virus.
    Schochetman G; Boehm-Truitt M; Schlom J
    J Immunol; 1976 Jul; 117(1):168-73. PubMed ID: 819581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interrelationship of reverse transcriptases of primate type D retroviruses.
    Wunderlich V; Sydow G; Micheel B
    Arch Geschwulstforsch; 1980; 50(3):214-9. PubMed ID: 6159867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic infection caused by the simian Mason-Pfizer virus in primate cell cultures].
    Nosik NN; Fein DL; Priori ES; Arthur L; Gonda MS; Pdauman DT; Ershov FI
    Vopr Virusol; 1978; (2):165-9. PubMed ID: 78587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autographa californica nucleopolyhedrovirus infection results in Sf9 cell cycle arrest at G2/M phase.
    Braunagel SC; Parr R; Belyavskyi M; Summers MD
    Virology; 1998 Apr; 244(1):195-211. PubMed ID: 9581791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human interferons inhibit replication of Mason-Pfizer monkey virus in primate cells.
    Chatterjee S; Hunter E
    Virology; 1987 Apr; 157(2):548-51. PubMed ID: 3824911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and immunological characterization of structural proteins from retrovirus-D/New England and comparison to Mason-Pfizer monkey virus and permanent human fibroblast virus.
    Uckert W; Wunderlich V; Fiebach H; Hertling I; Stein U; Kraft R; Desrosiers R
    Arch Virol; 1987; 94(3-4):267-82. PubMed ID: 3579611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Squirrel monkey retrovirus: electron microscopy of a virus from New World monkeys and comparison with Mason-Pfizer monkey virus.
    Gonda MA; Fine DL; Gregg M
    Arch Virol; 1978; 56(4):297-307. PubMed ID: 417701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mason-Pfizer monkey virus (MPMV) constitutive transport element (CTE) functions in a position-dependent manner.
    Rizvi TA; Schmidt RD; Lew KA
    Virology; 1997 Sep; 236(1):118-29. PubMed ID: 9299624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusion of transformed human cells by simian retroviruses.
    Ogura H; Tanaka T; Ocho M; Namba M; Oda T; Yabe Y
    Gan; 1980 Jun; 71(3):367-71. PubMed ID: 6252085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The characterization of Mason-Pfizer monkey virus-induced cell fusion.
    Chatterjee S; Hunter E
    Virology; 1979 Jun; 95(2):421-33. PubMed ID: 111409
    [No Abstract]   [Full Text] [Related]  

  • 18. Primate retroviruses: immunological cross-reactivity between major structural proteins of new and old world primate virus isolates.
    Devare SG; Arthur LO; Fine DL; Stephenson JR
    J Virol; 1978 Mar; 25(3):797-805. PubMed ID: 76686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of human lymphocyte mitogen response by retroviruses of type D. II. Non-activity of Mason-Pfizer monkey virus versus activity of human cell line derived virus PMFV.
    Denner J; Indzhiia L; Wunderlich V; Sydow G; Bierwolf D; Lapin BA
    Arch Virol; 1985; 86(3-4):187-96. PubMed ID: 4062558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Mason-Pfizer monkey virus and squirrel monkey (Saimiri sciureus) retrovirus by immunoelectron microscopy.
    Smith GC; Heberling RL; Kalter SS
    J Natl Cancer Inst; 1978 Aug; 61(2):411-3. PubMed ID: 79657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.